| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M701317200 |
| P698 | PubMed publication ID | 17785465 |
| P50 | author | Ernesto Canalis | Q56269284 |
| Stefano Zanotti | Q56269901 | ||
| Anna Smerdel-Ramoya | Q117248439 | ||
| Deena Durant | Q117248440 | ||
| Lisa Stadmeyer | Q117248442 | ||
| Aris Economides | Q37632525 | ||
| P2093 | author name string | Ernesto Canalis | |
| Elisabetta Gazzerro | |||
| P2860 | cites work | Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis | Q21145242 |
| Signal transduction of bone morphogenetic protein receptors | Q24302298 | ||
| Skeletal overexpression of gremlin impairs bone formation and causes osteopenia | Q24314447 | ||
| The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities | Q24314690 | ||
| Generalized lacZ expression with the ROSA26 Cre reporter strain | Q27860837 | ||
| Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells | Q27860926 | ||
| Identification of a secreted BMP antagonist, ectodin, integrating BMP, FGF, and SHH signals from the tooth enamel knot | Q28185030 | ||
| Overexpression of twisted gastrulation inhibits bone morphogenetic protein action and prevents osteoblast cell differentiation in vitro | Q44666805 | ||
| Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. | Q51009028 | ||
| Skeletal Overexpression of Noggin Results in Osteopenia and Reduced Bone Formation | Q57936901 | ||
| High-throughput engineering of the mouse genome coupled with high-resolution expression analysis | Q28202486 | ||
| Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling | Q28240767 | ||
| Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1 | Q28251731 | ||
| Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins | Q28293474 | ||
| Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis | Q28506504 | ||
| Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning | Q28507504 | ||
| Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor | Q28512188 | ||
| Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture | Q28576024 | ||
| Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin | Q28578839 | ||
| Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene | Q28776291 | ||
| Mechanisms of Wnt signaling in development | Q29547537 | ||
| A new logic for DNA engineering using recombination in Escherichia coli | Q29615202 | ||
| Secreted antagonists of the Wnt signalling pathway | Q29615521 | ||
| Validation of peripheral dual-energy X-ray absorptiometry for the measurement of bone mineral in intact and excised long bones of rats | Q31970416 | ||
| Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins | Q33697455 | ||
| Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts | Q33927389 | ||
| Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling | Q34049570 | ||
| RNA interference--2001. | Q34174586 | ||
| Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation | Q34569128 | ||
| Bone morphogenetic proteins and their antagonists | Q34572394 | ||
| Regulation of bone mass by Wnt signaling | Q34576629 | ||
| Wnt signaling: a key regulator of bone mass | Q34583328 | ||
| Bone morphogenetic proteins, their antagonists, and the skeleton | Q35109618 | ||
| Wnt signaling in osteoblasts and bone diseases | Q35913119 | ||
| Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo | Q37113932 | ||
| Bone morphogenetic protein-4 regulates its own expression in cultured osteoblasts | Q38316816 | ||
| Skeletal bone morphogenetic proteins suppress the expression of collagenase-3 by rat osteoblasts | Q38328853 | ||
| Effect of primary and secondary structure of oligodeoxyribonucleotides on the fluorescent properties of conjugated dyes | Q39600740 | ||
| Multiplex quantitative PCR using self-quenched primers labeled with a single fluorophore | Q39600850 | ||
| Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling | Q40331060 | ||
| The orphan receptor tyrosine kinase Ror2 modulates canonical Wnt signaling in osteoblastic cells | Q40511859 | ||
| Quantitative comparison of DNA looping in vitro and in vivo: chromatin increases effective DNA flexibility at short distances | Q40914602 | ||
| In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria | Q41387920 | ||
| Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia | Q42801302 | ||
| Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells | Q42818438 | ||
| The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. | Q42823613 | ||
| P433 | issue | 43 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 31549-31557 | |
| P577 | publication date | 2007-09-04 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Conditional deletion of gremlin causes a transient increase in bone formation and bone mass | |
| P478 | volume | 282 |
| Q90465698 | A Lox/CHOP-10 crosstalk governs osteogenic and adipogenic cell fate by MSCs |
| Q38965170 | A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 binding |
| Q41263199 | Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche |
| Q38896053 | Agonists and Antagonists of TGF-β Family Ligands |
| Q37236273 | Allelic depletion of grem1 attenuates diabetic kidney disease |
| Q37803542 | Animal models of typical heterotopic ossification |
| Q37328072 | Antisense makes sense in engineered regenerative medicine |
| Q37764890 | Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists |
| Q34025148 | Bone morphogenetic proteins and their antagonists: current and emerging clinical uses |
| Q52780111 | Coculture of meniscus cells and mesenchymal stem cells in simulated microgravity. |
| Q35872773 | Conditional inactivation of noggin in the postnatal skeleton causes osteopenia |
| Q34558047 | Cooperative activity of noggin and gremlin 1 in axial skeleton development |
| Q90104737 | DHA inhibits Gremlin-1-induced epithelial-to-mesenchymal transition via ERK suppression in human breast cancer cells |
| Q38109506 | Deconvoluting the ontogeny of hematopoietic stem cells |
| Q37482537 | Down-regulation of nestin in mesenchymal stem cells derived from peripheral blood through blocking bone morphogenesis pathway |
| Q37227357 | Effect of the methoxychlor metabolite HPTE on the rat ovarian granulosa cell transcriptome in vitro. |
| Q64104251 | Excessive mechanical loading promotes osteoarthritis through the gremlin-1-NF-κB pathway |
| Q37557031 | Expression of Potential Regulatory Genes in Abdominal Adipose Tissue of Broiler Chickens during Early Development |
| Q37619812 | Follistatin interacts with Noggin in the development of the axial skeleton |
| Q37690514 | GREM1, FRZB and DKK1 mRNA levels correlate with osteoarthritis and are regulated by osteoarthritis-associated factors. |
| Q38288247 | Generation and Applications of a DNA Aptamer against Gremlin-1. |
| Q90237184 | Gingival fibroblasts prevent BMP-mediated osteoblastic differentiation |
| Q57250932 | Gremlin 1, Frizzled-related protein, and Dkk-1 are key regulators of human articular cartilage homeostasis |
| Q37702395 | Gremlin promotes retinal pigmentation epithelial (RPE) cell proliferation, migration and VEGF production via activating VEGFR2-Akt-mTORC2 signaling. |
| Q35193538 | Gremlin, a bone morphogenetic protein antagonist, is a crucial angiogenic factor in pituitary adenoma |
| Q96640906 | Gremlin-1 augments the oestrogen-related receptor α signalling through EGFR activation: implications for the progression of breast cancer |
| Q42314422 | Gremlin-1 suppression increases BMP-2-induced osteogenesis of human mesenchymal stem cells |
| Q35093489 | Gremlin1 is required for skeletal development and postnatal skeletal homeostasis |
| Q34418716 | Growth factor control of bone mass |
| Q35755147 | High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes |
| Q35570723 | Loss of gremlin delays primordial follicle assembly but does not affect female fertility in mice |
| Q37526177 | MicroRNA miR-378 promotes BMP2-induced osteogenic differentiation of mesenchymal progenitor cells |
| Q34687339 | Nephroblastoma overexpressed (Nov) induces gremlin in ST-2 stromal cell lines by post-transcriptional mechanisms |
| Q47141932 | Neural EGF-like protein 1 (NELL-1): Signaling crosstalk in mesenchymal stem cells and applications in regenerative medicine. |
| Q46203128 | Protein related to DAN and cerberus (PRDC) inhibits osteoblastic differentiation and its suppression promotes osteogenesis in vitro |
| Q33980500 | Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse |
| Q38177814 | Review of Signaling Pathways Governing MSC Osteogenic and Adipogenic Differentiation. |
| Q26829340 | Ribonucleic acid interference induced gene knockdown |
| Q37539508 | Role of gremlin in the lung: development and disease |
| Q38248222 | Roles of bone morphogenetic protein signaling in osteosarcoma |
| Q35624042 | Strategies to minimize hypertrophy in cartilage engineering and regeneration |
| Q39308262 | TGF-β Family Signaling in Mesenchymal Differentiation |
| Q28087657 | Technologies for controlled, local delivery of siRNA |
| Q36087241 | The Role of Parathyroid Hormone-Related Protein (PTHrP) in Osteoblast Response to Microgravity: Mechanistic Implications for Osteoporosis Development |
| Q33786824 | Update in new anabolic therapies for osteoporosis |
| Q93197739 | WNT Signaling and Bone: Lessons From Skeletal Dysplasias and Disorders |
Search more.